Health Tech Forward Event 2024

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Provider of private equity investment services globally. The company's investment services include direct and fund of fund investments in the middle-market sector across all investment stages, enabling early access to investment opportunities and an ability to quickly add value to portfolio companies.

Developer of a predictive analytics platform designed to translate medical data into intelligent predictions to support and optimize clinical decisions. The company's platform supports maternal and neonatal applications to evaluate, optimize, and personalize medical strategies for the care of newborns, enabling medical practitioners to improve and personalize health care in early life and avoid long-term complications.

Developer and manufacturer of medical devices intended to manage cardiovascular health. The company offers products that provide personalized and precise management of cardiovascular risks, hypertension and peripheral artery disease (PAD) as well as screenings for vital parameters to identify risk factors that can lead to cardiovascular disease, thereby helping professionals measure what matters, prevent cardiovascular events and improve diagnosis and therapy efficiently.

Developer of a clinical data curation and analytics platform intended to combine technology and life sciences to accelerate drug development. The company's platform leverages artificial intelligence (AI) to explore large clinical datasets in collaboration with hospitals, pharmaceutical companies and software developers to assist in structuring images and paired clinical metadata in complex diseases, enabling health practitioners to identify novel biomarkers and understand diseases and therapeutic approaches.

Developer of a drug discovery platform designed to explore large and diverse chemical spaces. The company's platform uses a 3D representation of molecules based on electrostatic, steric and hydrophobic interaction fields derived from semi-empirical quantum-mechanics calculations, enabling bioinformaticians and medicinal chemists to obtain results using benchmarked technology and boost their drug discovery projects.

Developer of a clinical AI assistant designed to focus on enhancing clinical trials for both speed and cost efficiency. The company's platform offers access to clinical data for revolutionizing drug development through the power of artificial intelligence, enabling researchers to accelerate medical advancements and improve patient outcomes.

Developer of biomedical imaging technology designed to assist in pre-clinical and clinical trial applications. The company utilizes the photoacoustic effect to visualize and quantify anatomical, functional, and molecular information, in vivo, and deep tissue, and in real-time provides real-time visualization of anatomical, functional, and molecular information in living tissue, enabling doctors to detect tumors and inflammatory diseases without having to resort to invasive procedures.

BioMarin's focus is on rare-disease therapies. Genzyme markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU. Voxzogo (vosoritide) was approved in achondroplasia in 2021. BioMarin's Roctavian (hemophilia A gene therapy) was approved in Europe in 2022 and in the US in 2023.

Developer of an e-health station intended to measure vital signs and risk factors and calculate cardiovascular disease risks. The company offers a tool for healthcare automation and health check-ups in a few minutes, it also offers autonomous operation with automated umbilical venous catheter disinfection and privacy for optional remote appointments, enabling users to provide a scalable solution for preventive healthcare and check their health status.